April 2013
The essential resource for your practice
Volume XXI, Number 4

FDA Announces New Alerts on Supplements

In addition to the alerts announced by the Food and Drug Administration (FDA) late last month which were reported recently in the Health Policy Brief, the FDA last week issued several new announcements regarding the following sexual enhancement supplements: Ninja Mojo, Love Rider, and AFFIRM XL.

Table of Contents

  

Coding Corner:

Practice Management Conference Features Two Beneficial Coding Sessions

AUA Issues Comments on Regulatory Provisions Affecting Medicare

The AUA has a long history of challenging legislation and regulation that negatively impacts a urologist’s ability to provide quality patient care. This month, the AUA continued its efforts by signing on to a letter with U.S. House of Representatives Honorable Tom Price, MD, that supported the Medicare Patient Empowerment Act. In addition, the AUA submitted a comment letter on the Medicare and Medicaid Programs; Part II – Regulatory Provisions to Promote Program Efficiency, Transparency, and Burden Reduction – RIN 0938-AR49 to the Centers for Medicare and Medicaid Services’ (CMS) Acting Administrator Marilyn Tavenner

For The Record

According to a story in the online version of Medical Economics, published on March 27, 2013, the Centers for Medicare and Medicaid Services (CMS) has implemented a pre-payment auditing program for 2012-13 Meaningful Use incentive payments. The details of audits can be found at EHR Audit Overview FactSheet. The same contractor who conducts the post-payment audits, Figliozzi and Company, will randomly select five to ten percent of attestations to examine before the providers’ 2012 or 2013 incentive checks are sent out. Providers will be asked to provide data to back up their attestations and in some cases, the auditor may visit the site and require a demonstration of the electronic health records (EHR) system.

National Physician Payments Transparency Program

“The Physician Payments Sunshine Rule”
Affordable Care Act Section 6002 

The Centers for Medicare & Medicaid Services (CMS) released the Physician Payments Sunshine Final Rule on February 1, 2013. This rule requires applicable manufacturers of drugs, devices, biological, or medical supplies covered by Medicare, Medicaid, or Children’s Health Insurance Program to annually report to the Secretary of Health and Human Services certain payments or transfers of value provided to physicians or teaching hospitals, as well as ownership or investment interests in these companies. One of the major areas of concern for the physician community is how physician engagement in continuing medical education (CME) events will be affected.